Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The main purpose of the study is to evaluate the pharmacokinetics (PK) of a single oral dose of sotorasib administered in participants with moderate or severe hepatic impairment compared to participants with normal hepatic function.
Epistemonikos ID: eaa941098d1ceeddba041f44b3b7944d99d0cd9a
First added on: May 08, 2024